This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is titled "Atherosclerosis Assessment by Ultrasound in Everyday Practice." It is presented by Sharon Mulvagh M.D., FASE, FACC, FRCPC, professor of medicine, Dalhousie University, Halifax, Nova Scotia, Canada, and Mayo Clinic. This is one of the sessions presented at the ASE 2017 annual scientific sessions, one of the premier meetings for cardiac ultrasound education. For more information, visit asescientificsessions.org.
VIDEO: Why QT-prolongation Occurs in COVID-19 Patients on Hydroxychloroquine and Azithromycin
Interview with Andrew D. Krahn, M.D.,FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of medicine at the University of British Columbia, and vice president of the Heart Rhythm Society (HRS). He is an expert in long QT syndrome (LQTS) and is involved with the National Long QT Registry. He explains the issues with the drugs being used to treat coronavirus (COVID-19, SARS-CoV-2) patients and why these combined with the cardiac impact of the virus is causing prolonged ECG QT segment prolongation, leading to deadly arrhythmias. COVID-19 can cause myocarditis that causes QT prolongation and the front-line COVID drugs hydroxychloroquine and azithromycin also cause QT prolongation.
The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication April 23, 2020, reminding doctors there are serious side effects when using hydroxychloroquine and chloroquine in the off-label use to treat COVID-19 patients. This includes potentially life-threatening heart rhythm problems. The FDA said case reports from the FDA Adverse Event Reporting System database, published medical literature and the American Association of Poison Control Centers National Poison Data System are reporting serious heart-related adverse events and patient deaths. Read more about this alert.
The FDA warning confirmed fears from the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS). These societies April 8 jointly published a new guidance, “Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 19) Treatment,” to detail critical cardiovascular considerations in the use of hydroxychloroquine and azithromycin for the treatment of COVID-19. The societies warned that use of these agents in a large number of patients in combination would results in arrhythmias and deaths. Read more.
However, there are numerous advocates that argue hydroxychloroquine needs to be used in less sick patients who are not already hypoxic to treat COVID, but it is being used primarily in very sick patients where it is not effective. Advocates also argue the drug can be used to help prevent coronavirus, similar to the drug's effect in preventing malaria. In terms of drug safety, advocates argue the drug has been used in millions of patients for more than 50 years without a high risk of arrhythmias. Several trials are now underway in the United States to test its use against COVID-19, but enrollment has been hampered because of the FDA warning. There will likely be more interest in hydroxychloroquine after it was revealed May 18, 2020, that President Trump is taking the drug for prophylaxis against COVID-19.
Related Hydroxychloroquine Content:
VIDEO: Overview of Hydroxychloroquine and FDA Warning in its use to Treat COVID-19 — Interview with Marianne Pop, Pharm.D.
VIDEO: Cardiologists Manage Trial Testing if Hydroxychloroquine Protects Clinicians From COVID-19 — Interview with William O'Neill, M.D.
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medical Center, is leading a randomized clinical trial of a special vest device that can monitor fluid back up in the lungs of congestive heart failure patients so their medication can be adjusted before they even notice any symptoms. Video courtesy of the The Ohio State University Wexner Medical Center. Watch a VIDEO interview with Abraham on other heart failure technology advances that may help reduce readmissions, from TCT 2016.
Randall Thompson, M.D., outlines three new CPT codes for FFR-CT, a smart phone-based single-lead ECG system and PET nuclear perfusion imaging. Thompson is a professor of medicine at the University of Missouri, Kansas City, attending cardiologist, Mid-America Heart Institute, St. Luke’s Health, and member of the Society of Cardiovascular Computed Tomography (SCCT) Advocacy Committee, American College of Cardiology (ACC) Coding Taskforce and the American Society of Nuclear Cardiology (ASNC) treasurer, speaks at the SCCT 2017 annual meeting. Read the story "FFR-CT Gains CPT Code for Reimbursement."
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 2017 Heart Rhythm Society (HRS) annual meeting. This included new ablation and electromapping systems to improve cardiac ablation effectiveness, new wearable monitoring technologies that are replacing traditional Holter monitors, implantable cardiac monitors, new pacemaker and implantable cardioverter defibrillators (ICD), and other EP lab technologies.
A discussion with Heart Rhythm Society (HRS) President Michael Gold, M.D., Ph.D., director of cardiology and associate dean at the Medical University of South Carolina (MUSC), at the American College of Cardiology 2017 annual meeting. He discusses advances to treat atrial fibrillation, new ablation and electro mapping technologies and innovations in implantable devices.
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo floor at the 2017 meeting of the American College of Cardiology (ACC). For key technology trends at ACC.17, watch the VIDEO "Cardiac Technology Trends at ACC.17."
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system. It was cleared by the FDA in early 2017. It uses an ECG lead vest to noninvasively create a 3-D electrophysiology (EP) electro-map of the heart to help identify arrhythmia and plan catheter ablation procedures. Read the related article on the technology.
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology technologies he found at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 meeting. Watch the related VIDEO “Editor's Choice of the Most Innovative New Technologies at TCT 2015.”
ITN/DAIC Editor Dave Fornell takes a tour of some of the most innovative new trends and health information technologies (IT) on the expo floor of the Healthcare Information and Management Systems Society (HIMSS) 2016 meeting. Technologies include radiation dose management, wearables, patient engagement, admission kiosks, analytics software and imaging workflow aids.
DAIC Editor Dave Fornell takes a tour of some of the trends and interesting new technologies from the vendor booths on the expo floor at the 2016 meeting of the American College of Cardiology (ACC).
John Showalter, M.D., CHIO, University of Mississippi Medical Center, explains how he created population health monitoring programs to help identify high-risk patients that should receive extra attention to reduce readmissions.
He said electronic medical record data can be mined for information by smart computer algorithms to identify risk factors beyond clinical vital signs and test results. For example, if a heart failure patient has several doctor visits in his medical record for things that might be related to his heart failure symptoms, but there was failure for patient followup leading to a hospital admission. The algorithm also looks at things like the patient's address and its distance to their pharmacy, their socio-economic level and if they have a car and drive. He said these non-clinical factors outside of the hospital can have major impact on the ability of the patient to maintain medication compliance to help keep them out of the hospital.
Related Heart Failure Content:
DAIC/ITN Editor Dave Fornell shows examples of new healthcare IT technology at the 2015 HIMSS meeting that will change the future of healthcare. These include healthcare wearable devices, smart phone apps, virtual training software, population health data, and technology for patient engagement. See more exampled of how consumer healthcare technology is rapidly evolving in the VIDEO: Wearable Health Monitors and Apps at the 2018 Consumer Electronics Show.
At HIMSS 2015, one of the biggest trends was the explosion of consumer health related wearable devices and smartphone apps and how these will integrate into the healthcare system for improved patient monitoring and patient engagement. Thomas Martin, HIMSS director of health information systems, explains this trend and where these devices will fit in during the coming years. Read the article "How Wearables, Smartphones and Apps May Change the Face of Healthcare."
Mony Weschler, chief applications strategist and architect, application technology services, Montefiore Health System, New York, explains how he integrated enterprise imaging and mobile ECG waveform at Montefiore Health System.
DAIC Editor Dave Fornell shares his picks of the most interesting new devices and advances in cardiovascular technology shown on the expo floor at the 2015 American College of Cardiology (ACC) meeting.
The results from the CHAMPION Trial for the CardioMEMS device were presented at the American College of Cardiology (ACC) 2015. Principal Investigator William Abraham, M.D., professor, cardiovascular medicine, The Ohio State University, shares trial data and his experience with the system.
Learn how Lumedx can help hospitals reduce heart failure re-admissions and improve patient care with HealthView Heart Failure. The innovative solution integrates inpatient and home-health patient data.
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies shown on the expo floor at the American College of Cardiology (ACC) 2014 meeting.
A big trend in healthcare IT at HIMSS 2014 was the creation of enterprise-wide image access systems. With the introduction of vendor neutral archives (VNAs), enterprise imaging will increasingly be taken out of the hands of radiology and move to the responsibility of hospital IT directors. In this form, radiology may become just another department contributing images to the VNA. HIMSS also highlighted the proliferation of new, inexpensive home use patient monitors.
Agfa Healthcare introduced new functionality and workflow improvements for its completely revised cardiovascular information system (CVIS), introduced at the American College of Cardiology 2013 meeting. The CV12 system offers new solutions for echocardiography, nuclear perfusion imaging, cath lab reporting and ECG management and reporting. For more information, visit www.agfahealthcare.com
SunTech demonstrated its new Tango M2 cardiac stress test automated blood pressure monitoring system at the American College of Cardiology (ACC) 2013. The system eliminates the need to manually take blood pressure readings during a stress test, which can sometimes be difficult because of patient motion. It also allows clinicians to focus on the patient and the test instead of worrying about periodic blood pressure measurements. For more information, visit www.SunTechMed.com/TM2Info
Diagnostic and Interventional Cardiology Editor Dave Fornell shows some of the most innovative new technology displayed on the show floor at the Heart Rhythm Society (HRS) annual scientific sessions. The tour includes new devices and trends in electrophysiology. For more information: www.DIcardiology.com
During the American College of Cardiology (ACC) 2012 Scientific Session, McKesson displayed new features for its cardiovascular information system (CVIS). These included an electrophysiology (EP) reporting workflow, the addition of stress and Holter support and integrated inventory management. The features were shown as works-in-progress as part of the upcoming release of McKesson Cardiology v13.0, slated for release by early summer 2012. The EP reporting module integrates diagnostics including tilt tables, implantable devices and ablation treatment EP recording systems. For more information: www.allaboutCVIS.com
www.Womenheart.org is the only national organization dedicated to promoting women's heart health through advocacy, education and patient support. As the leading voice for the 42 million American women living with or at risk of heart disease, WomenHeart advocates for equal access to quality care and provides information and resources to help women take charge of their heart health. Lise Tate, CAE, CEO of WomenHeart, the National Coalition for Women With Heart Disease, said the non-profit group helps set up hospital support groups to guide women through their treatment and recovery. Since its inception, WomenHeart — founded by three women heart attack survivors who transformed the isolation, confusion and ignorance about women's heart disease into a rallying call to save women's lives — has been at the forefront of providing support services to women with heart disease and educating policymakers, health professionals and the public about the urgent need to make women's heart health a priority.
Founded in 1999, WomenHeart's mission is to improve the health and quality of life of women living with or at risk of heart disease. Through our programs and services, WomenHeart raises awareness about the importance of prevention and early detection, accurate diagnosis and proper treatment of women's heart disease. WomenHeart is a coalition and a community of thousands of members nationwide, including women heart patients and their families, physicians, health advocates and consumers committed to helping women live longer, healthier lives. At the center of the organization are the more than 500 WomenHeart Champions, all heart disease survivors, who have graduated from WomenHeart's Science and Leadership Symposium at the Mayo Clinic. These alumnae serve as WomenHeart local support group leaders, community educators, media spokeswomen, and general support volunteers. Through leadership and advocacy training, information resources and an online community, WomenHeart empowers women living with heart disease to manage their own heart health and to help all women take charge of their heart health.
For more information: www.womenheart.org